Quality of life of patients with irritable bowel syndrome before and after education

Joć, Ewa B; Mądro, Agnieszka; Celiński, Krzysztof; Słomka, Maria; Kasztelan-Szczerbińska, Beata; Pacian, Anna; Kulik, Teresa

doi:10.12740/pp/26078

Cited by 10 publications

(6 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Education on the therapeutic intervention should be provided in an empathetic and warm manner, providing ample time for the family to ask questions and to create a supportive patient-health professional relationship (70). Studies have not only shown the importance of dietary education for patients with FGID but also how more knowledge in general about the disorder, including pharmacological and nutritional therapy and the importance of follow-up, can enhance patient's quality of life (71,72). Ostgaard et al showed that adult patients with IBS who received two sessions of dietary guidance compared to those who did not, continued to have a healthy diet, improved quality of life, and reduced symptoms even after two years (73).…”

Section: Description Of Professional Guidance During the Dietary Trea...mentioning

confidence: 99%

An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology

Thomassen

Luque

Assa

et al. 2022

Journal of Pediatric Gastroenterology &Amp; Nutrition

View full text Add to dashboard Cite

Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered. Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present article provides practical safety tips to be applied when the low-FODMAP diet is considered in children.

show abstract

Section: Description Of Professional Guidance During the Dietary Trea...mentioning

confidence: 99%

An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology

Thomassen

Luque

Assa

et al. 2022

Journal of Pediatric Gastroenterology &Amp; Nutrition

View full text Add to dashboard Cite

show abstract

“…Management of IBS involves an integrated approach [53] and treatment options include establishment of an effective patient-provider relationship, education, reassurance, nutritional interventions, drug therapy and psychological therapy [8]. In fact, patients who received information about the course of the disease, disease-related diet and lifestyle, medications and check-ups had their quality of life improved [54].…”

Section: Managementmentioning

confidence: 99%

Irritable Bowel Syndrome: News from an Old Disorder

Ferreira

Garrido

Castro-Poças

2019

GE Port J Gastroenterol

View full text Add to dashboard Cite

Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder, which can affect all members of a society, regardless of age, sex, race or socioeconomic status. Because of its high prevalence and chronic nature, it represents a significant economic burden. In fact, these patients have a relevant impairment of their quality of life, which limits their work productivity and daily social activities, especially when it is associated with other disorders, such as anxiety and depression. The diagnosis of IBS relies on symptom-based diagnostic criteria with normal results on a limited number of complementary tests that rule out other possible diagnoses. The aetiology of this condition is incompletely established. However, evidence suggests that it is a multifactorial disorder with several different mechanisms that have been implicated as responsible for the symptoms. Since the treatment strategy is usually based on predominant symptoms and their severity, it is important to recognise the underlying mechanisms in order to successfully relief the visceral pain and altered bowel habits. The aim of this non-systematic review of the literature was to explore the pathophysiology and treatment options of IBS, highlighting the most recent evidence, from the new Rome IV criteria to the new drug armamentarium. Síndrome do intestino irritável: novidades de uma doença antiga Palavras ChaveSíndrome do intestino irritável · Revisão · Critérios Rome Resumo A síndrome do intestino irritável é um distúrbio gastrointestinal funcional, que pode afetar todos os membros da sociedade, independentemente da idade, sexo, raça ou estrato socioeconómico. Devido à sua elevada prevalência e natureza crónica, representa um encargo económico significativo. De facto, estes doentes apresentam uma alteração relevante da sua qualidade de vida, o que limita a sua produtividade laboral e atividades de vida diárias, sobretudo quando está associada a outros distúrbios, tais como ansiedade e depressão. O diagnóstico da síndrome do intestino irritável depende de critérios diagnósticos baseados em sintomas, com resultados normais num número limitado de testes complementares que exluem outros diagnósticos possíveis. A etiologia desta doença não está completamente estabelecida. No entanto, a evidência sugere que se trata de um distúrbio multifatorial com vários mecanismos diferentes que têm sido implicados como responsáveis pelos sintomas. Visto que a estratégia terapêutica é geralmente baseada nos sintomas predominantes e sua gravidade, é importante reconhecer os mecanismos subjacentes para aliviar com sucesso a dor visceral e a alteração dos hábitos intestinais. O objetivo desta revisão literária não sistemática consistiu em explorar a fisiopatologia e opções terapêuticas disponíveis para a síndrome do intestino irritável, realçando a evidência mais recente, desde os novos critérios Roma IV até ao novo arsenal farmacológico.

show abstract

“…Diagnosing an FD overlap syndrome may also present an ideal opportunity to provide more complete patient education about visceral hypersensitivity. 24 Visceral sensory abnormalities are common in DGBI and may contribute to the challenge of identifying the origin of refractory abdominal symptoms for both patients and clinicians. 25 Patients with a DGBI in one GI anatomic region frequently have additional symptoms referable to other parts of the gut 26 suggesting that visceral hypersensitivity may not respect anatomic boundaries and DGBI of different GI regions may in fact be manifestations of the same underlying pathophysiology.…”

Section: Discussionmentioning

confidence: 99%

Unrecognized Functional Dyspepsia Among Those With Refractory Chronic Constipation: Analysis of a Tertiary Cohort

Boyd¹,

Paz²,

Ahmad³

et al. 2023

Gastro Hep Advances

View full text Add to dashboard Cite

Quality of life of patients with irritable bowel syndrome before and after education

Cited by 10 publications

References 22 publications

An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology

An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology

Irritable Bowel Syndrome: News from an Old Disorder

Unrecognized Functional Dyspepsia Among Those With Refractory Chronic Constipation: Analysis of a Tertiary Cohort

Contact Info

Product

Resources

About